Skip to main content

Multiple Sclerosis & Neuroimmunology

The Multiple Sclerosis Clinic at Duke provides excellent patient care as well as clinical and basic research concerning immune diseases of the central nervous system. All of our providers have been named MS Certified Specialists by the Consortium of MS Centers.

Our providers have experience with a variety of injectable, oral, and infusion treatments for MS. They will work with you to find a therapy that meets your needs based on your symptoms and personal preferences.

Our clinic regularly participates in clinical trials to evaluate new treatments and treatment regimens for MS, including cyclosporine, beta-seron, avonex/rebif, and steroids for optic neuritis. Finally, we are an integral part of the Duke Center for Research in Autoimmunity and Multiple Sclerosis (DREAMS), a multidisciplinary group of basic and clinical researchers dedicated to improving our understanding of, and patient care for, MS and autoimmune diseases.

Latest News

image courtesy NIH
News  -  Epilepsy, Sleep, and Clinical Neurophysiology, General & Community Neurology, Hospital Neurology, Multiple Sclerosis & Neuroimmunology, Neurocritical Care, Neuromuscular Disease, Parkinson's Disease And Movement Disorders, Stroke and Vascular Neurology, , Translational Brain Sciences, , Neuromuscular Medicine/EMG

Duke Neurology Research Round Up, August 2020

Monday, August 3, 2020
Members of the Duke Neurology Department contributed to 14 new peer-reviewed articles published this July, improving our understanding of...Read more
image courtesy NIH
News  -  Epilepsy, Sleep, and Clinical Neurophysiology, Memory Disorders, Multiple Sclerosis & Neuroimmunology, Neurocritical Care, Neuromuscular Disease, Stroke and Vascular Neurology, , Clinical Neurophysiology, , Neurocritical Care, Neuromuscular Medicine/EMG, Vascular Neurology, Al La Spada, MD, PhD

Duke Neurology Research Round Up, July 2020

Tuesday, June 30, 2020
By William Alexander
New research from the Duke Neurology Department advanced our understanding of neurological diseases and patient care at the basic science,...Read more
S Gregory
News  -  Multiple Sclerosis & Neuroimmunology, Simon Gregory, PhD

Gregory selected to 10x Genomics CTRN

Monday, June 22, 2020
By Beth Rusnak, Duke Molecular Physiology Institute
The Molecular Genomics Core of Simon Gregory, PhD, was among the first 45 international members selected for participation in 10x Genomics Visium...Read more